Skip to main content
Log in

Effects of Pimobendan on the L-Type Ca2+ Current and Developed Tension in Guinea-Pig Ventricular Myocytes and Papillary Muscle: Comparison with IBMX, Milrinone, and Cilostazol

  • Published:
Cardiovascular Drugs and Therapy Aims and scope Submit manuscript

Abstract

Summary. In this study, we compared the effects of pimobenda (PIM), a putative Ca2+-sensitizer and phosphodiesterase (PDE) inhibitor, on the L-type Ca2+ current (ICa) of guinea-pig ventricular myocytes and contractile tension of ventricular papillary muscles with those of a nonselective PDE inhibitor, isobutylmethylxanthine (IBMX), and selective PDE-III inhibitors, that is, milrinone (MIL) and cilostazol (CIL). The efficacy (maximum attainable effect) of these drugs for increasing ICa or developed tension (DT) ranged in the order of IBMX ≫ MIL > PIM > CIL. This finding suggests that the positive inotropic effect of each drug is roughly proportional to its increasing effect on ICa. The additional effect of PIM (a Ca2+-sensitizing effect) was not identified in “intact” preparations, and the potentiating effects of PIM on the DT and ICa were virtually the same as those observed for MIL. To isolate the Ca2+-sensitizing effect of PIM on the DT, we studied the effects of PIM in the presence of H89, an isoquinoline derivative possessing a selective inhibitory effect on cAMP-dependent protein kinase. In the absence of H89, 50 µM PIM increased the DT by 68 ± 11% (mean ± SE, n = 6). However, in the presence of 20 µM H89, which completely blocked the PIM-induced increase in ICa, PIM (50 µM) significantly increased the DT by 19 ± 6% (n = 6), thereby indicating the presence of a positive inotropic effect attributable to a mechanism other than increased intracellular cAMP, that is, a Ca2+-sensitizing effect. The latter notion was supported by the finding that in the presence of H89 (20 µM), the PIM-induced augmentation of DT was accompanied by a prolongation of the time to 50% relaxation of contractile tension. In contrast, MIL (50 µM) and forskolin, a direct activator of adenylate cyclase (1–10 nM), did not increase DT in the presence of 20 µM H89. These results suggest that the fraction of positive inotropic effect of PIM attributable to its Ca2+-sensitizing effect is masked by its potent PDE-III inhibitory effect in “intact” ventricular preparations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Fujino K, Sperelakis N, Solaro RJ. Sensitization of dog and guinea pig heart myofilaments to Ca2+ activation and the inotropic effect of pimobendan: Comparison with milrinone. Circ Res 1988;63:911–922.

    Google Scholar 

  2. Lee JA, Ruegg JC, Allen DG. Effects of pimobendan, a novel inotropic agent, on intracellular calcium and tension in isolated ferret ventricular muscle. Clin Sci 1989;76:609–618.

    Google Scholar 

  3. Hagemeijer F. Calcium sensitization with pimobendan: Pharmacology, haemodynamic improvement, and sudden death in patients with chronic congestive heart failure. Eur Heart J 1993;14:551–566.

    Google Scholar 

  4. Cruickshank JM. Phosphodiesterase III inhibitors: Longterm risks and short-term benefits. Cardiovasc Drugs Ther 1993;7:655–660.

    Google Scholar 

  5. Kimura Y, Tani T, Kanbe T, Watanabe K. Effect of cilostazol on platelet aggregation and experimental thrombosis. Arzneimittelforschung 1985;35(II):1144–1149.

    Google Scholar 

  6. Chijiwa T, Mashima A, Hagiwara M, et al. Inhibition of forskolin-induced phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamyl amino) ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D pheochromocytoma cells. J Biol Chem 1990;265:5267–5272.

    Google Scholar 

  7. Muramatsu H, Kiyosue T, Arita M, Ishikawa T, Hidaka H. Modification of cardiac sodium current by intracellular application of cAMP. Pflügers Arch 1994;426:146–154.

    Google Scholar 

  8. Matsui K, Kiyosue T, Arita M. Effects of PDE-inhibitors on L-type Ca2+ current and developed tension in guinea pig ventricular myocytes and muscles. J Mol Cell Cardiol 1996;28:A311.

    Google Scholar 

  9. Taniguchi M, Kokubun S, Noma A, Irisawa H. Spontaneously active cells isolated from the sino-atrial and atrio-ventricular nodes of rabbit heart. Jpn J Physiol 1981;31:547–558.

    Google Scholar 

  10. Wang DW, Kiyosue T, Sato T, Arita M. Comparison of the effects of class I anti-arrhythmic drugs, cibenzoline, mexiletine and flecainide, on the delayed rectifier K+ current of guinea-pig ventricular myocytes. J Mol Cell Cardiol 1996;28:893–903.

    Google Scholar 

  11. Marty A, Neher E. Tight-seal whole-cell recording. In: Sakmann B, Neher E, eds. Single-Channel Recordings. New York: Plenum Press, 1983:107–122.

    Google Scholar 

  12. Tallarida RJ, Jakob LS (Eds). The Dose-Response Relation in Pharmacology. New York: Springer-Verlag, 1979.

    Google Scholar 

  13. Yuan W, Bers DM. Protein kinase inhibitor H-89 reverses forskolin stimulation of cardiac L-type calcium current. Am J Physiol 1995;268:C651–C659.

    Google Scholar 

  14. Arita M, Muramatsu H, Ono K, Kiyosue T. β-adrenergic regulation of cardiac Na+ channel. In: Morad M, Ebashi S, Trautwein W, Kurachi Y, eds. Molecular Physiology and Pharmacology of Cardiac Ion Channels and Transporters. Dordrecht: Kluwer Academic, 1996:53–62.

    Google Scholar 

  15. Seamon KB, Daly JW. Forskolin: A unique diterpene activator of cyclic AMP-generating systems. J Cycl Nucl Res 1981;7:201–224.

    Google Scholar 

  16. Tatsukawa Y, Arita M, Kiyosue T, Mikuriya Y, Nasu M. A comparative study of effects of isoproterenol and dihydroouabain on calcium transients and contraction in cultured rat ventricular cells. J Mol Cell Cardiol 1993;25:707–720

    Google Scholar 

  17. Tada M, Katz AM. Phosphorylation of the sarcoplasmic reticulum and sarcolemma. Annu Rev Physiol 1982;44:401–423.

    Google Scholar 

  18. Bethke T, Meyer W, Schmitz W, et al. Phosphodiesterase inhibition in ventricular cardiomyocytes from guinea pig hearts. Br J Pharmacol 1992;107:127–133.

    Google Scholar 

  19. Persons WJ, Ramkumar V, Stiles GL. Isobutylmethylxanthine stimulates adenylate cyclase by blocking the inhibitory regulatory protein, Gi. Mol Pharmacol 1988;34:37–41.

    Google Scholar 

  20. Atarashi H, Endoh Y, Saitoh H, Kishida H, Hayakawa H. Chronotropic effects of cilostazol, a new antithrombotic agent, in patients with bradyarrhythmias. J Cardiovasc Pharmacol 1998;31:534–539.

    Google Scholar 

  21. Scheld HH, Fritsche R, Schlepper M, van Meel JCA. Pimobendan increases calcium sensitivity of skinned human papillary muscle fibers. J Clin Pharmacol 1989;29:360–365.

    Google Scholar 

  22. DiFrancesco D, Tortota P. Direct activation of cardiac pacemaker channels by intracellular cyclic AMP. Nature 1991;351:145–147

    Google Scholar 

  23. Kelso EJ, McDermott BJ, Silke B. Differential effects of phosphodiesterase inhibitors on accumulation of cyclic AMP in isolated ventricular cardiomyocytes. Biochem Pharmacol 1995;49:441–452.

    Google Scholar 

  24. Kass RS, Lederer WJ, Tsien RW, Weingart E. Role of calcium ions in transient inward currents and aftercontractions induced by strophanthidin in cardiac Purkinje fibres. J Physiol 1978;281:187–208

    Google Scholar 

  25. Bohm M, Diet F, Feiler G, et al. Subsensitivity of the failing human heart to isoprenaline and milrinone is related to β-adrenoceptor downregulation. J Cardiovasc Pharmacol 1988;12:726–732

    Google Scholar 

  26. Feldman MD, Copelas L, Gwathmey JK, et al. Deficient production of cyclic AMP: Pharmacologic evidence of an important cause of contractile dysfunction in patients with end-stage heart failure. Circulation 1987;75:331–339.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Matsui, K., Kiyosue, T., Wang, JC. et al. Effects of Pimobendan on the L-Type Ca2+ Current and Developed Tension in Guinea-Pig Ventricular Myocytes and Papillary Muscle: Comparison with IBMX, Milrinone, and Cilostazol. Cardiovasc Drugs Ther 13, 105–113 (1999). https://doi.org/10.1023/A:1007779908346

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1007779908346

Navigation